BAR the door: Cancer suppression by amphiphysin-like genes

被引:54
作者
Prendergast, George C. [1 ,2 ]
Muller, Alexander J. [1 ,2 ]
Ramalingam, Arivudanambi [1 ]
Chang, Mee Young [1 ]
机构
[1] Lankenou Inst Med Res, Wynnewood, PA USA
[2] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2009年 / 1795卷 / 01期
关键词
Tumor suppressor; Modifier; Lung cancer; Vesicle trafficking; Indoleamine 2,3-dioxygenase; c-myc; Ras; Rho; C-MYC; TUMOR-SUPPRESSOR; INDOLEAMINE 2,3-DIOXYGENASE; PROTEIN-INTERACTION; CELL-PROLIFERATION; SH3; DOMAIN; FARNESYLTRANSFERASE INHIBITORS; ACTIN CYTOSKELETON; CRYSTAL-STRUCTURE; BIN1; ABLATION;
D O I
10.1016/j.bbcan.2008.09.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The evolutionarily conserved amphiphysin-like genes Bin1 and Bin3 function in membrane and actin dynamics, cell polarity, and stress signaling. Recent genetic studies in mice discriminate non-essential roles in endocytic processes commonly ascribed to amphiphysins from essential roles in cancer suppression. Bin I acts in default pathways of apoptosis and senescence that are triggered by the Myc and Raf oncogenes in primary cells, and Bin1 gene products display a 'moonlighting function' in the nucleus where a variety of other 'endocytic' proteins are also found. Together, genetic investigations in yeast, flies, and mice suggest that amphiphysin-like adapter proteins may suppress cancer by helping integrate cell polarity signals generated by actin and vesicle dynamics with central regulators of cell cycle arrest, apoptosis, and immune surveillance. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:25 / 36
页数:12
相关论文
共 148 条
[71]   Efficient in vivo manipulation of mouse genomic sequences at the zygote stage [J].
Lakso, M ;
Pichel, JG ;
Gorman, JR ;
Sauer, B ;
Okamoto, Y ;
Lee, E ;
Alt, FW ;
Westphal, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :5860-5865
[72]   Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle [J].
Lee, EY ;
Marcucci, M ;
Daniell, L ;
Pypaert, M ;
Weisz, OA ;
Ochoa, GC ;
Farsad, K ;
Wenk, MR ;
De Camilli, P .
SCIENCE, 2002, 297 (5584) :1193-1196
[73]   Interaction of yeast Rvs167 and Pho85 cyclin-dependent kinase complexes may link the cell cycle to the actin cytoskeleton [J].
Lee, J ;
Colwill, K ;
Aneliunas, V ;
Tennyson, C ;
Moore, L ;
Ho, YE ;
Andrews, B .
CURRENT BIOLOGY, 1998, 8 (24) :1310-1321
[74]   Sorting nexin 4 and amphiphysin 2, a new partnership between endocytosis and intracellular trafficking [J].
Leprince, C ;
Le Scolan, E ;
Meunier, B ;
Fraisier, V ;
Brandon, N ;
De Gunzburg, J ;
Camonis, J .
JOURNAL OF CELL SCIENCE, 2003, 116 (10) :1937-1948
[75]   Selection of a dominant negative retinoblastoma protein (RB) inhibiting satellite myoblast differentiation implies an indirect interaction between MyoD and RB [J].
Li, FQ ;
Coonrod, A ;
Horwitz, M .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (14) :5129-5139
[76]   Rvs161p and Rvs167p, the two yeast amphiphysin homologs, function together in vivo [J].
Lombardi, R ;
Riezman, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (08) :6016-6022
[77]   The murine Bin1 gene functions early in myogenesis and defines a new region of synteny between mouse chromosome 18 and human chromosome 2 [J].
Mao, NC ;
Steingrimsson, E ;
DuHadaway, J ;
Wasserman, W ;
Ruiz, JC ;
Copeland, NG ;
Jenkins, NA ;
Prendergast, GC .
GENOMICS, 1999, 56 (01) :51-58
[78]   Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak [J].
McCarthy, NJ ;
Whyte, MKB ;
Gilbert, CS ;
Evan, GI .
JOURNAL OF CELL BIOLOGY, 1997, 136 (01) :215-227
[79]   APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment [J].
Miaczynska, M ;
Christoforidis, S ;
Giner, A ;
Shevchenko, A ;
Uttenweiler-Joseph, S ;
Habermann, B ;
Wilm, M ;
Parton, RG ;
Zerial, M .
CELL, 2004, 116 (03) :445-456
[80]   Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2 [J].
Mitsuuchi, Y ;
Johnson, SW ;
Sonoda, G ;
Tanno, S ;
Golemis, EA ;
Testa, JR .
ONCOGENE, 1999, 18 (35) :4891-4898